Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOLTAIRE-X: BI 695501 vs Humira in Psoriasis
NCT03210259Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2017
- Primary completion
- Apr 2019
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 3 trial of adalimumab-adbm in plaque psoriasis, sponsored by Boehringer Ingelheim. Started Jul 2017; status: completed.
02
Drugs
adalimumab-adbm
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03210259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210259.